GenToX is Now Offering Inherited Cancer Testing
Industry Leader in Pharmacogenomics is now offering inherited cancer screenings for patients to enhance their personalized medical testing services.
King of Prussia, PA, July 10, 2015 --(PR.com)-- Today, GenToX Inc, a pharmacogenomics and toxicology testing company specializing in personalized medicine, announced that they will now offer inherited cancer testing for their customers.
“We are excited to be able to provide this new testing to patients with hereditary cancer risks,” said CEO Matthew Bennett. “GenToX worked diligently to be able to provide these screenings because of the extremely important information that they provide to patients and their families,” Bennett said.
Patients who can benefit from this testing are those with a family history of cancer and those that would like to know their likelihood of developing the disease.
After a sample is collected from the patient, the test will be sent to our labs for analysis. The labs analyze 33 different genes, including the BRCA1 and BRCA2, which possess a high risk for certain high risk cancers such as breast cancer, colon cancer, and thyroid cancer.
Once the lab report is generated patients can take the information to their providers and personalize any preventative measures that may be right for them.
“The ability to provide this testing is a key ingredient in advancing the personalized medicine movement. Our ultimate goal is for patients to take back control of their health and make any type of medical treatment work for them,” Bennett said, “Inherited Cancer Testing at GenToX allows the patient to do just that.”
If you would like more information on inherited cancer testing at GenToX including determining if this type of testing is right for you, contact a representative today at 1-800-417-2239.
Background on GenToX, Inc.
GenToX™ is a pharmacogenomic, inherited cancer, and toxicology testing company located in King of Prussia, PA. Our pharmacogenomic testing analyzes a patient’s DNA and the results help guide doctors on how well a patient metabolizes certain medications, providing personalized medical care. All of our tests come with a comprehensive report for any doctor, hospital, nursing home or healthcare plan. For more information about testing in your area, visit http://www.gentoxtesting.com.
“We are excited to be able to provide this new testing to patients with hereditary cancer risks,” said CEO Matthew Bennett. “GenToX worked diligently to be able to provide these screenings because of the extremely important information that they provide to patients and their families,” Bennett said.
Patients who can benefit from this testing are those with a family history of cancer and those that would like to know their likelihood of developing the disease.
After a sample is collected from the patient, the test will be sent to our labs for analysis. The labs analyze 33 different genes, including the BRCA1 and BRCA2, which possess a high risk for certain high risk cancers such as breast cancer, colon cancer, and thyroid cancer.
Once the lab report is generated patients can take the information to their providers and personalize any preventative measures that may be right for them.
“The ability to provide this testing is a key ingredient in advancing the personalized medicine movement. Our ultimate goal is for patients to take back control of their health and make any type of medical treatment work for them,” Bennett said, “Inherited Cancer Testing at GenToX allows the patient to do just that.”
If you would like more information on inherited cancer testing at GenToX including determining if this type of testing is right for you, contact a representative today at 1-800-417-2239.
Background on GenToX, Inc.
GenToX™ is a pharmacogenomic, inherited cancer, and toxicology testing company located in King of Prussia, PA. Our pharmacogenomic testing analyzes a patient’s DNA and the results help guide doctors on how well a patient metabolizes certain medications, providing personalized medical care. All of our tests come with a comprehensive report for any doctor, hospital, nursing home or healthcare plan. For more information about testing in your area, visit http://www.gentoxtesting.com.
Contact
Gentox
Matt Bennett
610-291-7417
www.gentoxtesting.com
Matt Bennett
610-291-7417
www.gentoxtesting.com
Contact
Categories